These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8895560)

  • 1. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.
    Kelliher MA; Seldin DC; Leder P
    EMBO J; 1996 Oct; 15(19):5160-6. PubMed ID: 8895560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
    O'Neil J; Billa M; Oikemus S; Kelliher M
    Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
    Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
    Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
    Goldfarb AN; Lewandowska K
    Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
    Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
    Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.
    Goardon N; Schuh A; Hajar I; Ma X; Jouault H; Dzierzak E; Roméo PH; Maouche-Chrétien L
    Blood; 2002 Jul; 100(2):491-500. PubMed ID: 12091340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
    Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
    Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB activation in premalignant mouse tal-1/scl thymocytes and tumors.
    O'Neil J; Ventura JJ; Cusson N; Kelliher M
    Blood; 2003 Oct; 102(7):2593-6. PubMed ID: 12816868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
    Goldfarb AN; Greenberg JM
    Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
    Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
    Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.
    Hsu HL; Cheng JT; Chen Q; Baer R
    Mol Cell Biol; 1991 Jun; 11(6):3037-42. PubMed ID: 2038315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCL/Tal-1 expression in T-acute lymphoblastic leukemia: an immunohistochemical and genotypic study.
    Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K
    Hum Pathol; 1995 Sep; 26(9):994-8. PubMed ID: 7672800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
    Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
    Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.
    Leroy-Viard K; Vinit MA; Lecointe N; Mathieu-Mahul D; Roméo PH
    Blood; 1994 Dec; 84(11):3819-27. PubMed ID: 7949138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade.
    Condorelli GL; Tocci A; Botta R; Facchiano F; Testa U; Vitelli L; Valtieri M; Croce CM; Peschle C
    Mol Cell Biol; 1997 May; 17(5):2954-69. PubMed ID: 9111367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
    Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
    Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
    Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
    J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TAL-1 proteins in human tissues.
    Pulford K; Lecointe N; Leroy-Viard K; Jones M; Mathieu-Mahul D; Mason DY
    Blood; 1995 Feb; 85(3):675-84. PubMed ID: 7833471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.